Showing results (661-670 of 1,271) with videos related to
Sort By:
Pageof 128
Psychopharmacology Bulletin|January 1, 1991
Pharmacokinetics of neurolepticsC Verghese, J B Kessel, G M SimpsonPsychopharmacology Bulletin|June 7, 2021
A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812 (Viloxazine Extended-Release) in Adolescents with ADHDAzmi Nasser, Tesfaye Liranso, Toyin Adewole, et al.Psychopharmacology Bulletin|July 11, 2022
Possible Lurasidone-Associated Dose-Dependent QTc Prolongation in First-Episode PsychosisAhmed Naguy, Suliman Al-Khadhari, Saxby PridmorePsychopharmacology Bulletin|July 11, 2022
Influence of CYP2C19*17 Genetic Polymorphism on the Steady-State Concentration of Escitalopram in Patients with Recurrent Depressive DisorderM S Zastrozhin, VYu Skryabin, F Rwere, et al.Psychopharmacology Bulletin|January 1, 1997
Consensus methods in practice guideline development: a review and description of a new methodD A Kahn, J P Docherty, D Carpenter, et al.Psychopharmacology Bulletin|January 1, 1997
Measuring outcomes and costs for major depressionB M Booth, M Zhang, K M Rost, et al.Psychopharmacology Bulletin|January 1, 1997
Antidepressant overdoses and resultant emergency department services: the impact of SSRIsS C Stoner, P A Marken, W A Watson, et al.Psychopharmacology Bulletin|January 1, 1997
The cognitive, subjective, and physical effects of a ginkgo biloba/panax ginseng combination in healthy volunteers with neurasthenic complaintsK A Wesnes, R A Faleni, N R Hefting, et al.Psychopharmacology Bulletin|January 1, 1997
Intracellular phosphatidylinositol pathway abnormalities in bipolar disorder patientsJ C Soares, A G MallingerPsychopharmacology Bulletin|January 1, 1997
Low-level serum anticholinergicity as a source of baseline cognitive heterogeneity in geriatric depressed patientsR D Nebes, B G Pollock, B H Mulsant, et al.Pageof 128